J-M Andrieu - JoVE Visualize

Showing results (81-90 of 100) with videos related to

Pageof 10

Sort By:

The Journal of Infectious Diseases|March 1, 1990

Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007

Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patientsS Oudard, E Banu, F Scotte, et al.

Clinical Immunology and Immunopathology|May 1, 1988

Effects of cyclosporin on T-cell subsets in human immunodeficiency virus diseaseJ M Andrieu, P Even, A Venet, et al.

European Journal of Haematology|October 1, 1987

Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year resultsP Colonna, J M Andrieu, R Ghouadni, et al.

Cancer|April 1, 1990

Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patientsJ M Tourani, J F Timsit, C Delaisement, et al.

Blood|January 1, 1993

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patientC Soubrane, J M Tourani, J M Andrieu, et al.

Bulletin Du Cancer|January 1, 1990

Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patientsJ M Tourani, D Penaud, I Caubarrere, et al.

Clinical and Experimental Immunology|July 1, 1988

Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsetsJ M Andrieu, D Eme, A Venet, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993

Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated TumorsJ M Andrieu, S Roithmann, J M Tourani, et al.

American Journal of Hematology|March 1, 1989

Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiationP Colonna, J M Andrieu, R Ghouadni, et al.

Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:

Pageof 10

The Journal of Infectious Diseases|March 1, 1990

Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007

Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patientsS Oudard, E Banu, F Scotte, et al.

Clinical Immunology and Immunopathology|May 1, 1988

Effects of cyclosporin on T-cell subsets in human immunodeficiency virus diseaseJ M Andrieu, P Even, A Venet, et al.

European Journal of Haematology|October 1, 1987

Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year resultsP Colonna, J M Andrieu, R Ghouadni, et al.

Cancer|April 1, 1990

Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patientsJ M Tourani, J F Timsit, C Delaisement, et al.

Blood|January 1, 1993

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patientC Soubrane, J M Tourani, J M Andrieu, et al.

Bulletin Du Cancer|January 1, 1990

Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patientsJ M Tourani, D Penaud, I Caubarrere, et al.

Clinical and Experimental Immunology|July 1, 1988

Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsetsJ M Andrieu, D Eme, A Venet, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993

Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated TumorsJ M Andrieu, S Roithmann, J M Tourani, et al.

American Journal of Hematology|March 1, 1989

Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiationP Colonna, J M Andrieu, R Ghouadni, et al.

Pageof 10